05/06/2024
VitalTrace is revolutionizing childbirth safety with its groundbreaking biosensor technology, aimed at mitigating the risks associated with childbirth for mothers and babies worldwide. Despite childbirth being a joyous occasion, it remains perilous, with outdated fetal heart rate monitoring methods dating back to the 1960s, leading to inaccuracies and errors. Inaccurate fetal monitoring results in preventable deaths and diseases, including catastrophic brain injury in babies due to hypoxia during labor and unnecessary C-sections in mothers.
The DelivAssure™ continuous lactate monitor (CLM) by VitalTrace is a world-first solution that measures the most accurate biomarker of fetal distress in real-time, enabling clear and safe decision-making during childbirth. Previously available only through in-utero blood tests, this vital data is now accessible in real-time, thanks to VitalTrace's innovative sensor technology. Endorsed by obstetricians globally and designated as a Breakthrough Device by the FDA, VitalTrace's device system is set to undergo its landmark clinical trial in six months, paving the way for expedited market approval.
This cutting-edge platform technology, featuring precision-manufactured sensors integrated into bio wearables, is proudly manufactured in Western Australia, underscoring VitalTrace's commitment to local innovation and global impact. VitalTrace brings peace of mind to childbirth, one heartbeat at a time, ensuring safety for both mother and baby.